CLINICAL_TRIALS
trial_result
· 2024-10-30
Clinical Trial Update: A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 trial of amivantamab as monotherapy in previously treated advanced hepatocellular carcinoma was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: TERMINATED | Results posted: 2024-10-30